Literature DB >> 8906540

Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity.

J V Bonventre1.   

Abstract

Phospholipase A2 (PLA2) activity is an important contributor to destructive cellular processes in the central nervous system. Two cytosolic forms of calcium independent PLA2 have been characterized in the gerbil brain and the neuronal cultures from rat brain. PLA2 enzymatic activity in cell free extracts from cortical neuronal cultures is upregulated after cells are exposed to glutamate. Brief exposure to a calcium ionophore or phorbol 12-myristate 13-acetate (PMA) stably enhanced PLA2 activity. Stable activation of the two cytosolic forms of PLA2 occur prior to evidence of cell death and this activation is reversible. The larger molecular mass form was characterized as cPLA2. The smaller form (approximately 14 kDa) was distinct from Group I and II PLA2. Exposure to glutamate shifted the calcium activation curve of the smaller form to the left suggesting a novel mechanism of regulation of PLA2. Glutamate-induced stable enhancement of PLA2 activity, by processes involving calcium and protein kinase C activation, is a potential molecular switch likely mediating changes in synaptic function and contribution to excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906540     DOI: 10.1016/0929-7855(96)00503-2

Source DB:  PubMed          Journal:  J Lipid Mediat Cell Signal        ISSN: 0929-7855


  11 in total

Review 1.  Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.

Authors:  Andreas Stahl; Tim U Krohne; Przemyslaw Sapieha; Jing Chen; Ann Hellstrom; Emily Chew; Frank G Holz; Lois E H Smith
Journal:  Br J Ophthalmol       Date:  2011-03-18       Impact factor: 4.638

2.  Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.

Authors:  Xiao-Xia Fang; Xiao-Lin Jiang; Xin-Hua Han; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Cell Mol Neurobiol       Date:  2012-11-16       Impact factor: 5.046

3.  The role of phospholipase A2 in calcium-ionophore-mediated injury to rat gastric mucosal cells.

Authors:  B L Tepperman; B D Soper
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

4.  Cortical impact injury in rats promotes a rapid and sustained increase in polyunsaturated free fatty acids and diacylglycerols.

Authors:  P Homayoun; N E Parkins; J Soblosky; M E Carey; E B Rodriguez de Turco; N G Bazan
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

5.  Characterizing phospholipase A2-induced spinal cord injury-a comparison with contusive spinal cord injury in adult rats.

Authors:  Nai-Kui Liu; William Lee Titsworth; Yi Ping Zhang; Aurela I Xhafa; Christopher B Shields; Xiao-Ming Xu
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

Review 6.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

Review 7.  Role of Ca2+-independent phospholipase A2 in cell growth and signaling.

Authors:  Shelley B Hooks; Brian S Cummings
Journal:  Biochem Pharmacol       Date:  2008-08-15       Impact factor: 5.858

Review 8.  Phospholipase A2 and its molecular mechanism after spinal cord injury.

Authors:  Nai-Kui Liu; Xiao-Ming Xu
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.682

9.  Inhibition of Cytosolic Phospholipase A2 Has Neuroprotective Effects on Motoneuron and Muscle Atrophy after Spinal Cord Injury.

Authors:  Nai-Kui Liu; James S Byers; Tom Lam; Qing-Bo Lu; Dale R Sengelaub; Xiao-Ming Xu
Journal:  J Neurotrauma       Date:  2021-05-01       Impact factor: 4.869

10.  Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury.

Authors:  Nai-Kui Liu; Ling-Xiao Deng; Yi Ping Zhang; Qing-Bo Lu; Xiao-Fei Wang; Jian-Guo Hu; Eddie Oakes; Joseph V Bonventre; Christopher B Shields; Xiao-Ming Xu
Journal:  Ann Neurol       Date:  2014-04-02       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.